The widely used breast cancer drug tamoxifen (Nolvadex), which can become less effective over time, might retain its full strength indefinitely if used along with a second drug, according to new research in mice conducted by investigators from the National Cancer Institute, part of the National Institutes of Health, and their partners.
The population of breast cancer cells that gives rise to a tumor may be relatively resistant to radiotherapy and may even increase when given multiple treatments of radiation, a new study shows.
Use of cholesterol-lowering medications called statins is not associated with a lower risk of prostate cancer overall, but it is associated with a decreased risk of advanced disease, a large prospective study finds.
A longer, less intense course of radiotherapy provides better value for the money than a shorter, more intense regimen when given to ease pain and other complaints in patients with late-stage non-small-cell lung cancer (NSCLC), according to a study in the December 20 issue of the Journal of the National Cancer Institute.
Viewing prior mammograms in association with current mammograms significantly improves radiologist performance and may decrease unnecessary recalls by up to 44 percent, according to a study in the January issue of Radiology.
A tiny implant now being developed at MIT could one day help doctors rapidly monitor the growth of tumors and the progress of chemotherapy in cancer patients.
Breast Cancer Action (BCA) released a report today, in conjunction with a poster presentation at the San Antonio Breast Cancer Symposium, on the side effects of aromatase inhibitors (AIs). The report, “Side Effects Revealed: Women’s Experiences with Aromatase Inhibitors,” analyzes 612 women’s responses to an online survey of the drugs’ side effects.
An enzyme found at elevated levels in several human cancers has been linked to abnormal tumor growth in fruit flies, a discovery that provides a new model for understanding the link between stem cell biology and cancer, according to researchers at the University of Oregon.
The latest Gamma Knife? technology is now available at Cedars-Sinai with the opening of the Gamma Knife Center at the Samuel Oschin Comprehensive Cancer Institute.
In 2003, breast cancer incidence in the United States dropped sharply, and this decline may largely be due to the fact that millions of older women stopped using hormone replacement therapy (HRT) in 2002, according to a new analysis led by researchers at The University of Texas M. D. Anderson Cancer Center.